Loading company…
China-based biopharmaceutical company researching and developing biological polypeptides and protein drugs.
Established in 2016 and based in China, McAllen is a biopharmaceutical company focused on researching and developing Biological 1.1 polypeptides and protein drugs. The company is at the Seed stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in